ArticleFrontiers in immunology2025

Telitacicept as double-targeted therapy for myasthenia gravis coexisting with connective tissue disease: three case reports.

Yingying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.